Elisa Perego

Dr. Elisa Perego

UCL
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Social Science & Medicine
Verified
Journal Article
Open access
FCFelicity Callard
Felicity Callard
EPElisa Perego
Elisa Perego
Patients collectively made Long Covid – and cognate term ‘Long-haul Covid’ – in the first months of the pandemic. Patients, many with initially ‘mild’ illness, used various kinds of evidence and advocacy to demonstrate a longer, more complex course of illness than laid out in initial reports from Wuhan. Long Covid has a strong claim to be the first illness created through patients finding one another on Twitter: it moved from patients, through various media, to formal clinical and policy channels in just a few months. This initial mapping of Long Covid – by two patients with this illness – focuses on actors in the UK and USA and demonstrates how patients marshalled epistemic authority. Patient knowledge needs to be incorporated into how COVID-19 is conceptualised, researched, and treated.

24 September 2020 in Wellcome Open Research
Verified
Journal Article
Open access
PDF file
EPElisa Perego
Elisa Perego
FCFelicity Callard
Felicity Callard
LSLaurie Stras
Laurie Stras
BMBarbara Melville-Jóhannesson
Barbara Melville-Jóhannesson
RPRachel Pope
Rachel Pope
NANisreen Alwan
Nisreen Alwan
The patient-made term ‘Long Covid’ is, we argue, a helpful and capacious term that is needed to address key medical, epidemiological and socio-political challenges posed by diverse symptoms persisting beyond four weeks after symptom onset suggestive of coronavirus disease 2019 (COVID-19). An international movement of patients (which includes all six authors) brought the persistence and heterogeneity of long-term symptoms to widespread visibility. The same grassroots movement introduced the term ‘Long Covid’ (and the cognate term ‘long-haulers’) to intervene in relation to widespread assumptions about disease severity and duration. Persistent symptoms following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are now one of the most pressing clinical and public health phenomena to address: their cause(s) is/are unknown, their effects can be debilitating, and the percentage of patients affected is unclear, though likely significant. The term ‘Long Covid’ is now used in scientific literature, the media, and in interactions with the WHO. Uncertainty regarding its value and meaning, however, remains. In this Open Letter, we explain the advantages of the term ‘Long Covid’ and bring clarity to some pressing issues of use and definition. We also point to the importance of centring patient experience and expertise in relation to ‘Long Covid’ research, as well as the provision of care and rehabilitation.

18 March 2026 in COVID
Verified
Journal Article
Open access
PDF file
EPElisa Perego
Elisa Perego
Long COVID is the disease entity triggered and potentially driven by SARS-CoV-2 infection. It is an heterogeneous condition characterized by dozens of different symptoms, signs and sequelae, which can affect all organs and body systems and evolve over the disease course. Clinical manifestations of Long COVID can vary from individual to individual and across the broader patient population. Pathology can range from asymptomatic and subclinical manifestations to fatal outcomes. Over 400 million people worldwide are estimated to suffer, or have suffered, from Long COVID, making the sequelae of SARS-CoV-2 infection one of the greatest public health challenges of the 21st century. This article provides an updated overview of epidemiology, definitions, main concepts and terminology for Long COVID. It also summarizes key evidence of pathology and disease mechanisms in major organs and body systems, such as the immune system, cardiovascular system, endothelium, heart, lungs, central nervous system, peripheral nervous system, gastrointestinal system, hapatobiliary system, pancreas and kidney. Heterogeneity in manifestations, potential risk of death and the degree of disability in several disease subsets call for timely diagnosis of each Long COVID types and a fuller understanding of their pathophysiological underpinnings. Further research is recommended to better understand pathobiology, develop effective clinical trials, and identify treatments and scalable biomarkers.

19 December 2022 in Papers From the Institute of Archaeology
Verified
Journal Article
Open access
PDF file
MSMassimo Saracino
Massimo Saracino
LZLorenzo Zamboni
Lorenzo Zamboni
VZVera Zanoni
Vera Zanoni
EPElisa Perego
Elisa Perego
This report presents the preliminary results of the ‘‘IN or OUT’’ Project, a collaborative, interdisciplinary effort which aims to investigate social exclusion, marginality and the adoption of anomalous funerary rites in late prehistoric Italy. In particular, this contribution explores the incidence and meaning of practices of ritual marginalisation and funerary deviancy in the region of Veneto between the Bronze Age and the early Iron Age period.

15 August 2025 in COVID
Verified
Journal Article
Open access
PDF file
EPElisa Perego
Elisa Perego
SARS-CoV-2 infection can be followed by prolonged symptoms, signs and sequelae, collectively known under the term Long COVID. Hundreds of millions are estimated to suffer from Long COVID. Long COVID, therefore, is a public health crisis that deserves the utmost urgency from all relevant stakeholders, from policymakers to advocacy groups, researchers and healthcare providers. The development of effective definitions and guidelines for Long COVID is crucial to support patients and carers. In this review, I address the following two case definitions of Long COVID developed in the US as a case study for a broader discussion on the sequelae of SARS-CoV-2 infection: the U.S. Government (USG) working definition for Long COVID and the NASEM definition published in 2024. In the first part of this review, I provide a critical appraisal of the USG in light of research, pathophysiology and lived experience, building upon my intervention as a patient expert on a National Academies of Sciences, Engineering, and Medicine (NASEM) panel for defining Long COVID, which examined the USG. In the second part, I raise some pressing concerns to address when approaching Long COVID as a disease entity and as a concept, which I originally submitted to NASEM. In the third part, I offer a critical appraisal of the NASEM definition, the most recent benchmark for Long COVID in the US. The review highlights the importance of broad, expansive and inclusive definitions for Long COVID, accounting for the disease’s heterogeneous, fluctuating and multi-system manifestations. Clinical case definitions for Long COVID must retain their focus on the broader spectrum and scope of the disease entity, while incorporating feedback from people with lived experience, advocates and patient-researchers.

7 October 2024
Verified
Book Chapter
Open access
PDF file
PAPetra Amann
Petra Amann
GBGiorgio Baratti
Giorgio Baratti
EBEnrico Benelli
Enrico Benelli
MBMartin Bentz
Martin Bentz
CVCaruso Valentina
Caruso Valentina
PZPatrick Zeidler
Patrick Zeidler
Notes on Contributors was published in Dependency and Social Inequality in Pre-Roman Italy on page 401.